Dr. Jessica Richman is co-founder and CEO of uBiome, which uses big data to understand bacteria. uBiome has filed over 100 patents on its technology with Dr. Richman as a co-inventor, and has launched the world's first sequencing-based clinical microbiome testing. uBiome has raised $22m from Y Combinator, Andreesen Horowitz, 8VC, and other leading investors.
Dr. Richman studied computer science and economics at Stanford University, and then received a fellowship to Oxford, where she received her Masters and PhD and was awarded a Fulbright Scholarship. Her work has been featured in the New York Times, Wall Street Journal, Wired, MIT Technology Review, Scientific American, NPR, and dozens of other media outlets.